This week's Fierce Biotech is brought to you by Patheon.

Trouble viewing? Click here.


                                                           
 
 

Thermo Fisher Scientific's Monza, Italy site, specializing in prefilled syringe and cartridge manufacturing, has established a new state-of-the-art center of excellence for sterile injectables development. All manufacturing services are fully supported with comprehensive in-house analytical and bioanalytical capabilities. Additionally, the facility employs Qualified Persons (QPs) to ensure prompt release of bulk products within the European market. Specific capabilities include:

  • Prefilled syringes
  • Sterile lyophilized products
  • Sterile liquids (SVP)
  • Cartridges
  • Biopharmaceuticals
  • Controlled drugs
  • Secondary packaging (vials)
  • Commercial Fill / Finish Lines
  • Visual Inspection Capabilites
  • 100% Automatic Visual Inspection
  • Semiautomatic Visual Inspecion
  • Manual Visual Inspection

Take a virtual tour of the Monza site by click the "Learn More" button below. 


 
 
 
 

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact [email protected] or call 202-824-5074.



You are currently subscribed as [email protected].
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor  
New York, NY 10017